| Year |
Citation |
Score |
| 2016 |
Woods NT, Baskin R, Golubeva V, Jhuraney A, De-Gregoriis G, Vaclova T, Goldgar DE, Couch FJ, Carvalho MA, Iversen ES, Monteiro AN. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance. Npj Genomic Medicine. 1. PMID 28781887 DOI: 10.1038/Npjgenmed.2016.1 |
0.635 |
|
| 2016 |
Jhuraney A, Woods NT, Wright G, Rix L, Kinose F, Kroeger JL, Remily-Wood E, Cress WD, Koomen JM, Brantley SG, Gray JE, Haura EB, Rix U, Monteiro AN. PAXIP1 potentiates the combination of WEE1 inhibitor AZD1775 and platinum agents in lung cancer. Molecular Cancer Therapeutics. PMID 27196765 DOI: 10.1158/1535-7163.Mct-15-0182 |
0.624 |
|
| 2015 |
Jhuraney A, Velkova A, Johnson RC, Kessing B, Carvalho RS, Whiley P, Spurdle AB, Vreeswijk MP, Caputo SM, Millot GA, Vega A, Coquelle N, Galli A, Eccles D, Blok MJ, et al. BRCA1 Circos: a visualisation resource for functional analysis of missense variants. Journal of Medical Genetics. 52: 224-30. PMID 25643705 DOI: 10.1136/Jmedgenet-2014-102766 |
0.648 |
|
| 2015 |
Woods NT, Jhuraney A, Monteiro AN. Incorporating computational resources in a cancer research program. Human Genetics. 134: 467-78. PMID 25324189 DOI: 10.1007/S00439-014-1496-3 |
0.627 |
|
| 2014 |
Jhuraney A, Woods NT, Kinose F, Cress DW, Gray JE, Haura EB, Rix U, Monteiro AN. Abstract 2414: Overexpression of PAXIP1 potentiates WEE1 inhibitor action in lung cancer cells Cancer Research. 74: 2414-2414. DOI: 10.1158/1538-7445.Am2014-2414 |
0.624 |
|
| 2012 |
Jhuraney A, Velkova A, Vallée MP, Carvalho RS, Tavtigian SV, Monteiro AN. Abstract 4444: BRCA1 Circos: A visualization tool for BRCA1 missense variants Cancer Research. 72: 4444-4444. DOI: 10.1158/1538-7445.Am2012-4444 |
0.705 |
|
| Show low-probability matches. |